Share:
Peer-Reviewed Publication
J Mol Diagn2021;23(5):612-629.May 1, 2021Journal Article

Intronic Breakpoint Signatures Enhance Detection and Characterization of Clinically Relevant Germline Structural Variants.

Jeroen van den Akker1, Lawrence Hon2, Anjana Ondov2, Ziga Mahkovec2, Robert O'Connor2, Raymond C Chan2, Justin Lock2, Anjali D Zimmer2, Asha Rostamianfar2, Jeremy Ginsberg2, Annette Leon2, Scott Topper2
1Color Genomics, Burlingame, California. Electronic address: jeroen@color.com.
2Color Genomics, Burlingame, California.

Abstract

The relevance of large copy number variants (CNVs) to hereditary disorders has been long recognized, and population sequencing efforts have chronicled many common structural variants (SVs). However, limited data are available on the clinical contribution of rare germline SVs. Here, a detailed characterization of SVs identified using targeted next-generation sequencing was performed. Across 50 gene…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.